These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 21325806

  • 21. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 22. Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma.
    Hakenberg OW, Fuessel S, Richter K, Froehner M, Oehlschlaeger S, Rathert P, Meye A, Wirth MP.
    Urology; 2004 Dec; 64(6):1121-6. PubMed ID: 15596183
    [Abstract] [Full Text] [Related]

  • 23. The dilemma of suspicious urine cytology in patients being followed for bladder cancer.
    Raitanen MP, Aine R, Kylmälä T, Kallio J, Liukkonen T, Tammela T, Finnbladder Group.
    Ann Chir Gynaecol; 2001 Dec; 90(4):256-9. PubMed ID: 11820413
    [Abstract] [Full Text] [Related]

  • 24. [Clinical value of combined detection with urinary bladder cancer antigen, hyaluronic acid and cytokeratin 20 in diagnosis of bladder cancer].
    Pu XY, Wang ZP, Chen YR, Wu YL, Wang HP, Wang XH.
    Ai Zheng; 2008 Sep; 27(9):970-3. PubMed ID: 18799038
    [Abstract] [Full Text] [Related]

  • 25. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J, Rodríguez-Martínez JJ, Barmadah SE, García Rodríguez J, Allende DM, Jalon A, Gonzalez R, Alvarez-Múgica M.
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
    Gajda M, Tyloch F, Jóźwicki W, Tyloch J, Sujkowska R, Skok Z.
    Int J Occup Med Environ Health; 1995 May; 8(2):103-8. PubMed ID: 7582848
    [Abstract] [Full Text] [Related]

  • 27. Usefulness of NMP22 as an adjunct to a typical urine cytology and low-grade urothelial carcinoma.
    Arora VK, Sarungbam J, Bhatia A, Singh N, Agrawal V, Aggarwal S.
    Diagn Cytopathol; 2010 Nov; 38(11):788-90. PubMed ID: 20014314
    [Abstract] [Full Text] [Related]

  • 28. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A, Kumar R, Gupta NP.
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [Abstract] [Full Text] [Related]

  • 29. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer.
    Sánchez-Carbayo M, Urrutia M, Silva JM, Romaní R, De Buitrago JM, Navajo JA.
    J Urol; 2001 May; 165(5):1462-7. PubMed ID: 11342897
    [Abstract] [Full Text] [Related]

  • 30. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
    Raica M, Miclea F, Ioiart I, Minciu R, Drăgan P.
    Rom J Morphol Embryol; 1998 May; 44(1-4):173-8. PubMed ID: 15678859
    [Abstract] [Full Text] [Related]

  • 31. [Value of urinary cytology and cytology of bladder lavage in the diagnosis and observation of bladder cancer].
    Denis L, Nowé P, Reiss S, Declercq G.
    Acta Urol Belg; 1983 May; 51(1):38-42. PubMed ID: 6858797
    [No Abstract] [Full Text] [Related]

  • 32. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
    Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson JS.
    J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
    [Abstract] [Full Text] [Related]

  • 33. Cytohistological study of urinary bladder neoplasms.
    Misra V, Gupta SC, Tandon SP, Gupta AK, Sircar S.
    Indian J Pathol Microbiol; 2000 Jul; 43(3):303-9. PubMed ID: 11218677
    [Abstract] [Full Text] [Related]

  • 34. FISHing and beyond in urinary cytology.
    Dahmoush L, Cohen MB.
    Diagn Cytopathol; 2004 Oct; 31(4):201. PubMed ID: 15386797
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.